Neuroscience
Permanent URI for this collectionhttps://hdl.handle.net/20.500.12503/21691
Browse
Browsing Neuroscience by Author "Chaudhari, Kiran"
Now showing 1 - 2 of 2
- Results Per Page
- Sort Options
Item Artemisinin Protects Oxidative Stress-induced Neuronal Apoptosis Via Up-Regulation of Akt/Bcl-2 Signaling(2017-03-14) Liu, Ran; Xie, Luokun; Li, Wenjun; Winters, Ali; Chaudhari, Kiran; Prah, Jude; Yang, Shao-Hua; Lin, Shao-PengPurpose: Artemisinin is a powerful anti-malarial drug that has been in use for decades. Recently, the novel biological effects of artemisinin on cancer, inflammation-related disorders, and cardiovascular disease were reported. The aim of this study was to explore the neuroprotective actions of artemisinin. Methods: The model of glutamate-induced oxidative injury in HT22 hippocampal cells was established to simulate cellular ischemic model. We investigated the effect of artemisinin on oxidative stress-induced cell apoptosis death and the activity of Akt/Bcl-2 pathway in HT22 cells. Results: Pretreatment with artemisinin attenuated reactive oxygen species (ROS) generations, preventing the decline of mitochondrial membrane potential and rescued the HT22 cells form glutamate-induced apoptosis death. The Akt/Bcl-2 pathway was activated by artemisinin in time dependent manner. Furthermore, the artemisinin inhibitor MK2206 blocked the neuroprotective effect of artemisinin. Conclusions: Artemisinin protects neuronal HT22 cell from glutamate-induced oxidative injury and apoptosis via Akt/Bcl-signaling, thereby might be applicated for clinical neurological therapy.Item Sex Dependent Alteration in Psychomotor and Cognitive Functions After Chronic Metformin Treatment(2017-03-14) Winters, Ali; Shetty, Ritu; Li, Wenjun; Xie, Luokun; Prah, Jude; Liu, Ran; Sumien, Nathalie; Yang, Shaohua; Chaudhari, KiranPurpose: Metformin, the most commonly used anti-hyperglycemic medication has been proposed to have delayed aging and longevity benefits. Without due consideration to gender/sex influence, metformin administration is being tested for non-diabetic benefits. Amid mixed reports on cognition, the purpose of the current study was to identify the influence of sex variation in the psychomotor and cognitive outcomes after long term metformin treatment. Materials and Methods: Young normo-glycemic male and female C57BL/6J mice (aged 4 mo, n=10 each; total n=40 mice) were randomly assigned to either a control group or metformin group (administered 2 mg/ml in drinking water). After 1 month of treatment, a battery of behavioral tests was initiated to assess the psychomotor and cognitive functions. Metformin treatment was continued during behavior assessment. Results: Overall female mice weighed lesser than male mice. Over the experiment time span, metformin neither altered the body weight nor decreased the blood glucose level significantly. There was no variation in muscle strength or reflexes between male and female mice on either treatment. Male mice were more anxious than female mice and metformin treatment decreased anxiety in male mice only. Female mice had better motor learning and maximum coordinated running performance than male mice. Metformin treatment improved motor learning only in male mice. Metformin treatment improved balance function irrespective of sex. Overall male mice had better retention of long term memory which was deteriorated after metformin treatment. Further, metformin impaired the short term memory and cognitive flexibility only in male mice. Conclusions: This study demonstrated that metformin affects psychomotor or cognitive function differently influenced by sex. Our results suggested that chronic metformin was beneficial for psychomotor function and detrimental for short term and long-term memory in male sex. While, in female sex, metformin had beneficial or no effects on brain functions.